CBD MED Research Corp. Announces a Corporate Update Modification on Warrant Terms of $300,000 Private Placement

Vancouver, British Columbia--(Newsfile Corp. - November 14, 2014) - CBD MED Research Corp. (TSXV: CBM.H) ("The Company") announced on October 3, 2014, a four year term warrant in conjunction with a private placement of 5,000,000 units priced at 0.06 cents to raise up to $300,000, for general working capital.

The new term of the warrant will be 12 months convertible into one share of 0.08 cents. The 12-month term is in compliance with NEX policy for private placement financing terms.

On behalf of the Board of Directors,

CBD Med Research Corp.

"Gary F. Zak"
President, CEO

Email: gzak1@shaw.ca
Tel: 604-802-7551

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, including the likelihood of commercial mining and possible future financings are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include unsuccessful business results, changes in forecast prices, changes in the availability of funding for proposed business plans, unanticipated changes in key management personnel and general economic conditions. Accordingly the actual events may differ materially from those projected in the forward-looking statements. For more information on the Company and the risks and challenges of its business, investors should review the Company’s annual filings that are available at www.sedar.com.

*THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES*